SCHEMBL25818344

SCHEMBL25818344

CCc1ccn2c1COCC2

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 10/20 0.34
DRD3 P35462 2/20 0.33
ATM Q13315 1/20 0.32
PKM P14618 1/20 0.32
FKBP1A P62942 1/20 0.31
CYP2A13 Q16696 1/20 0.31
IDO1 P14902 1/20 0.31
HSD17B10 Q99714 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28812475 0.82 CYP2C9 (0.33) CYP2A13HSD17B10MEN1ALDH1A1MAPT
SCHEMBL15166031 0.76 ABCB1 (0.38) KCNK3ATMKDM4EALDH1A1MAPT
SCHEMBL25817832 0.73 MAPT (0.35) KCNK3FKBP1AHSD17B10MEN1MAPT
SCHEMBL29910887 0.70 KMT2A (0.34) DRD3HSD17B10KDM4EMEN1ALDH1A1
SCHEMBL21576237 0.70 LRRK2 (0.38) DRD3
SCHEMBL15157482 0.70 HTT (0.37) KCNK3PKMMAPTTDP1L3MBTL1
SCHEMBL30791523 0.69 KDM4E (0.38) KCNK3HSD17B10KDM4EMEN1ALDH1A1
SCHEMBL21569481 0.68 KMT2A (0.35) DRD3HSD17B10KDM4EMEN1ALDH1A1
SCHEMBL17591393 0.68 KCNK3 (0.69) KCNK3
SCHEMBL25529231 0.66 ALDH1A1 (0.40) HSD17B10KDM4EMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227427-A1 IL-17A MODULATORS SANOFI (FR) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227427-A1 IL-17A MODULATORS IL17A, IL2, IL15 KCNK3 3845/4885DRD3 4081/4885ATM 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.